These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Safety and efficacy of thrombolysis during ambulance transportation of patients with an acute heart infarct].
    Author: Oemrawsingh PV, Bosker HA, Manger Cats V, van der Laarse A, Bruschke AV.
    Journal: Ned Tijdschr Geneeskd; 1989 Feb 18; 133(7):354-8. PubMed ID: 2927553.
    Abstract:
    We studied the safety and efficacy of thrombolytic therapy for acute myocardial infarction initiated prior to ambulance transport. Intravenous streptokinase with 5 X 10(5) IU (SK-i.v.) was started in 40 patients (group A) before transport and 36 patients (group B) after transport. In all patients immediate coronary angiography was performed, followed by intracoronary streptokinase. Infarct size was assessed from cumulative release of alpha-hydroxybutyrate dehydrogenase. No procedure-related complications were seen during transport. The time to SK-i.v. was 70 minutes in group A versus 125 minutes in group B. At first visualisation the infarct-related vessel was patent in 23 patients (58%) in group A and in 6 patients (17%) in group B (p less than 0.001). For anterior wall infarction we found a 32% smaller infarct size in group A (p less than 0.05). We conclude that SK-i.v. during ambulance transport is safe, increases early reperfusion and leads to a further reduction of infarct size which is significant in anterior wall infarction.
    [Abstract] [Full Text] [Related] [New Search]